Evidence map›Paper›PMID 25581274›Full record

ArticleHead & neck2016

Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.

John Cuaron, Shyam Rao, Suzanne Wolden, Michael Zelefsky, Karen Schupak, Borys Mychalczak, Nancy Lee

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

John CuaronDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Shyam RaoDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Suzanne WoldenDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Michael ZelefskyDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Karen SchupakDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Borys MychalczakDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Nancy LeeDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundThe purpose of this study was to examine patterns of failure and the relationship to radiation doses in patients with head and neck carcinoma of unknown primary (HNCUP).

methodsWe reviewed 85 patients with HNCUP treated with curative-intent radiation therapy (RT) during 1995 to 2012.

resultsThere have been no failures in the pharyngeal axis. Relapse at initial neck sites of disease developed in 7 patients (8.2%). The median dose to these sites was 70 Gy (range, 63-70 Gy). Failure at neck sites without initial disease occurred in 4 patients (4.7%). The median dose was 54 Gy (range, 50-58.8 Gy). There were no contralateral failures in a small cohort of patients receiving unilateral treatment (n = 6). Percutaneous endoscopic gastrostomy (PEG) tube dependence at 12 months was 7.4%, and 2.5% at 3 years. Esophageal stricture developed in 5 patients (5.9%).

conclusionRT for HNCUP produces excellent locoregional control rates with acceptably low levels of late toxicity. Doses prescribed to sites of eventual failure did not vary significantly from those sites that were treated and remain in control. © 2015 Wiley Periodicals, Inc. Head Neck 38: E426-E431, 2016.

Indexed as

Radiotherapy DosageAdultAgedAged, 80 and overCarcinoma, Squamous CellEsophageal StenosisFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasms, Unknown PrimaryRetrospective Studieshead and neckradiation therapyunknown primary

Identifiers

PMID25581274
PMCPMC5508510
OpenAlexW1554236968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.